drugset / Trial / NCT02820311
Thorough QT (TQT) Study of TD-4208 in Healthy Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to evaluate if TD-4208, an investigational drug being developed to treat people with chronic obstructive pulmonary disease (COPD), has any effect on the electrical activity of the heart.
Timeline
- Start
- 2016-05
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
| Subject | Revefenacin | Small molecule | 175 ug | Other |
| Subject | Revefenacin | Small molecule | 700 ug | Other |
Indications
No indication recorded.